Trial intelligence / Profile preview

Fenofibrate and Metformin Combinations in Metabolic Syndrome

NCT00703755Phase 2Completed

Sponsor
Solvay
Start
Mar 2003
Primary completion
Jun 2004
Modality
Small Molecules
Countries
9
01

Overview

A Phase 2 trial of fenofibrate, metformin in metabolic syndrome, sponsored by Solvay. Started Mar 2003; status: completed.

02

Drugs

fenofibratemetformin
03

Conditions

metabolic syndrome

Beyond the preview

Go deeper on NCT00703755.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00703755.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call